Abstract
OBJECTIVE: To test the reliability, clinical and psychometric validity of the Brain Symptom and Impact Questionnaire (BASIQ) in patients with brain metastases.
METHODS: Brain metastases patients were interviewed using the BASIQ, Functional Assessment of Cancer-Brain (FACT-Br) and FACT-General (FACT-G) at baseline, with a follow-up assessment at 1 month.
RESULTS: Forty patients had complete one data and the median age was 64 years. Patients with higher KPS, ECOG of 2, primary breast cancer, or >3 brain metastases, scored higher on the symptom scale of the BASIQ. All subscales showed no significant change in patient symptoms from baseline to follow-up.
CONCLUSION: This study supports that the reliability, clinical and psychometric validity of BASIQ to be used in brain metastases patients.
Original language | English (US) |
---|---|
Pages (from-to) | 11-23 |
Number of pages | 13 |
Journal | CNS oncology |
Volume | 4 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2015 |
Keywords
- BASIQ
- brain metastases
- field-testing
- psychometric validation
- quality of life
- questionnaire
ASJC Scopus subject areas
- General Medicine